XML 59 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 1,565 $ 1,591
Investments and restricted cash and cash equivalents 1,253 2,141
Trade receivables, net 2,667 2,876
Inventories 1,509 1,256
Mortgage loans held for sale 451 474
Regulatory assets 1,398 1,319
Other current assets 1,355 1,345
Total current assets 10,198 11,002
Property, plant and equipment, net 99,248 93,043
Goodwill 11,547 11,489
Regulatory assets 4,167 3,743
Investments and restricted cash and cash equivalents and investments 9,510 11,273
Other assets 3,170 3,290
Total assets 137,840 133,840
Current liabilities:    
Accounts payable 3,175 2,679
Accrued interest 625 558
Accrued property, income and other taxes 828 746
Accrued employee expenses 354 333
Short-term debt 4,148 1,119
Subsidiary debt, current 2,740 3,201
Other current liabilities 1,551 1,677
Total current liabilities 13,421 10,313
BHE senior debt 13,101 13,096
BHE junior subordinated debentures 100 100
Subsidiary debt 36,231 35,238
Regulatory liabilities 6,644 7,070
Deferred income taxes 12,437 12,678
Other long-term liabilities 6,166 4,706
Total liabilities 88,100 83,201
Commitments and contingencies
Shareholders' equity:    
Preferred stock 0 850
Common stock 0 0
Additional paid-in capital 5,573 6,298
Retained earnings 44,765 41,833
Accumulated other comprehensive loss, net (1,904) (2,149)
Total shareholder's equity 48,434 46,832
Noncontrolling interests 1,306 3,807
Total equity 49,740 50,639
Total liabilities and shareholder's equity $ 137,840 $ 133,840